Data Analysis as part of the Assessment Process - PowerPoint PPT Presentation

1 / 31
About This Presentation
Title:

Data Analysis as part of the Assessment Process

Description:

CHD8 compared with lipid lowering prescribing. What to target ... CHD8 Cholesterol less than 5 - 17. BP4 BP recorded in past 9 months - 20 ... – PowerPoint PPT presentation

Number of Views:41
Avg rating:3.0/5.0
Slides: 32
Provided by: jillb3
Category:

less

Transcript and Presenter's Notes

Title: Data Analysis as part of the Assessment Process


1
Data Analysis as part of the Assessment Process
  • Jill Burke
  • Insight Solutions

2
Who are we?
  • Established since 2001
  • Independent IT training consultancy
  • Not affiliated to any of the clinical suppliers
  • Designated Clinical System trainers for all major
    systems
  • Working with 2500 practices
  • Working in over 75 PCOs/LHBs
  • Accredited training Company
  • main contract software suppliers
  • Welsh Assembly Government
  • nGMS Contract Training specialists
  • IT Training Specialists for Primary Care

3
Ethical Disclaimer
  • All information provided during this presentation
    is an opinion and is, therefore, optional. It is
    designed to enhance your abilities to work with
    the nGMS Contract should you wish
  • It is based on how QoF 2 stands today! There are
    likely to be many changes, it is the
    responsibility of the practice to ensure they
    keep up-to-date with any future changes made
  • The decision to implement any changes rest
    entirely with each practice/clinician

4
Why?
  • Assessments in the past have often been routine
  • Assessors going through learning curve
  • Practices expecting you to look at patient data
    for evidence
  • Largest investment in Primary Care
  • Practice income higher than ever before

5
Where are we now?
  • QoF2
  • Established a process of assessing
  • Identified a need to move this forward
  • 2 years of back data and information from QoF
  • years of other information
  • Prescribing data
  • Prevalence
  • 2 years experience of assessing
  • But not necessarily using all the information
    together

6
Where do we want to be?
  • Assessing practices
  • Accurately, consistently and relevantly
  • Justifying payments
  • Confident practice have achieved as a result of
    hard work
  • Not just ticking boxes

7
Benefits outside of QoF?
  • Chronic Disease management
  • Powerful information for commissioning of
    services
  • Community Matrons
  • Admissions Prevention
  • Practice Based Commissioning
  • Accurate Disease Prevalence
  • Budget Setting
  • Better Patient Services
  • Patient Pathways

8
Data AnalysisA new dimension
9
Three Approaches
  • Comparing expected and observed prevalence rates
  • Identifying high levels of exception reporting
  • Comparing prescribing and prevalence rates
  • Approaches will identify lines of enquiry not
    definitive answer to questions of gaming
  • Making assessments worthwhile

10
1. Prevalence Rates
  • QMAS reports crude prevalence rates not
    adjusted for risk factors (age, sex ethnicity
    etc)
  • Very high / low rates might be explained by these
    factors
  • Doncaster PCT have generated a tool that refines
    expected prevalence rates for 7 conditions based
    on practice level socio-demographic factors

11
Data required
  • Practice Level
  • Reported prevalence rates (QMAS)
  • Age sex breakdown
  • Deprivation
  • PCT will need to data entry into spreadsheet
    time consuming but worthwhile results

12
Model Output
13
(No Transcript)
14
(No Transcript)
15
2.Exception Reporting
  • Exception reporting codes concerns
  • over-use
  • under use
  • misuse
  • Comparison can be made with reference to PCT
    average level of exception reporting and size of
    disease register
  • QMAS provides data on levels of exception
    reporting

16
Automatically identifies indicators where the
practice varies from PCT average
17
Locate data in QMAS
18
Download into Spreadsheet
19
A few simple calculations
20
Produce Control Chart
21
(No Transcript)
22
3. Comparing Prescribing and Prevalence Rates
  • One would expect strong association between
    prevalence rates and prescribing rates for
    chronic diseases
  • Variance from expected might indicate inaccurate
    registers
  • School of Medicines Management (Keele Uni) have
    investigated this approach

23
CHD Register Size vs Chapter 2 Prescribing
EXAMPLE
24
CHD Register Size vs Chapter 2 Prescribing
Poor Data Quality? Patients not identified on
Registers
Poor Data Quality Inflated registers?
25
Practice to benefit
  • If prevalence is high and incorrect, practice
    targeted to deliver services to patients who not
    in need
  • More work
  • Less success
  • Fewer points
  • If prevalence is low and incorrect , practice may
    be doing the work but not getting recognition
  • Less per point

26
Patient to Benefit
  • Correct services offered to relevant patients
  • Patient care to improve
  • Practices dont waste patients time

27
PCT to Benefit
  • Correct investment of public money
  • Patient services improved
  • Practice achievement improves

28
Other possible checks
  • Hypertension prevalence vs anti-hypertensive
    prescribing
  • BP5 vs anti-hypertensive large amount of points
  • Asthma and COPD prevalence vs BNF Chapter 3
    prescribing
  • Diabetes prevalence vs diabetic prescribing
  • Epilepsy prevalence vs anti-epileptic prescribing
  • CHD8 compared with lipid lowering prescribing

29
What to target
  • With so many areas / indicators / disease
    registers be selective
  • Identify which registers / indicators are best
    for target
  • High points potentially expensive for PCTs if
    there is concern
  • Speciality within practice/PCT
  • Diabetes
  • Asthma etc.

Use data analysis to establish this
30
High Point Indicators
  • CHD5 BP less that 150/90 - 19
  • CHD8 Cholesterol less than 5 - 17
  • BP4 BP recorded in past 9 months - 20
  • BP5 BP less than 150/90 - 57
  • DM20 HbA1c 7.5 or less - 17
  • MH9 review in past yr - 23
  • Asthma3 variability/reversibility - 15
  • Asthma6 review - 20
  • DEM2 review - 15
  • DEP2 assessment - 25
  • AF3 anticoagulation/platelet - 15
  • Smoking - 68

31
Best use of data
  • Pointless to have all this data and use it in
    isolation
  • Cross referencing all sources
  • E.g. Prescribing versus prevalence
  • Prescribing versus achievement
  • Exception reporting versus Prevalence
  • Practice to practice comparisons

32
Summary
  • Data will need to be collected, prepared,
    analysed and understood before the assessment
  • Assessors should have the questions ready to ask
  • May need practice input for some data
  • Standard approach across PCT for all practices
  • Target areas pre defined
  • Training if required
  • Assessors need to see the benefit
  • May require specific training e.g. Excel
Write a Comment
User Comments (0)
About PowerShow.com